Showing results (101-110 of 193) with videos related to
Sort By:
Pageof 20
Hepatology (Baltimore, Md.)|September 3, 2009
Pharmacological inhibition of integrin alphavbeta3 aggravates experimental liver fibrosis and suppresses hepatic angiogenesisEleonora Patsenker, Yury Popov, Felix Stickel, et al.Journal of Hepatology|January 29, 2008
Integrin alphavbeta6 is a marker of the progression of biliary and portal liver fibrosis and a novel target for antifibrotic therapiesYury Popov, Eleonora Patsenker, Felix Stickel, et al.Plos One|December 31, 2020
Nut consumption and the prevalence and severity of non-alcoholic fatty liver diseaseGeorg Semmler, Sebastian Bachmayer, Sarah Wernly, et al.Nature Reviews. Disease Primers|August 30, 2018
Publisher Correction: Alcoholic liver diseaseHelmut K Seitz, Ramon Bataller, Helena Cortez-Pinto, et al.Gastroenterology|May 29, 2008
Copper availability contributes to iron perturbations in human nonalcoholic fatty liver diseaseElmar Aigner, Igor Theurl, Heike Haufe, et al.Nature Reviews. Disease Primers|August 18, 2018
Alcoholic liver diseaseHelmut K Seitz, Ramon Bataller, Helena Cortez-Pinto, et al.Zeitschrift Fur Gastroenterologie|January 18, 2022
Liver specific, systemic and genetic contributors to alcohol-related liver disease progressionBernd Schnabl, Gavin E Arteel, Felix Stickel, et al.Wiener Klinische Wochenschrift|April 27, 2023
No association of NAFLD-related polymorphisms in PNPLA3 and TM6SF2 with all-cause and cardiovascular mortality in an Austrian population studyGeorg Semmler, Lorenz Balcar, Sarah Wernly, et al.Liver International : Official Journal of the International Association for the Study of the Liver|August 11, 2015
Natural course of subjects with elevated liver tests and normal liver histologyMichael Strasser, Andreas Stadlmayr, Heike Haufe, et al.Journal of Hepatology|May 12, 2005
Association of myeloperoxidase promotor polymorphism with cirrhosis in patients with hereditary hemochromatosisChristoph H Osterreicher, Christian Datz, Felix Stickel, et al.Pageof 20